SCP2D1, or Sterol Carrier Protein 2 Domain Containing 1, is a protein that has not been extensively characterized in scientific literature, and as such, there is limited information available on its specific function and role within cellular biology. The SCP2D1 designation may not correspond to a widely recognized protein name in scientific databases or publications, and it could be a less-studied protein whose details have yet to be elucidated.
When proteins are not well-characterized, their names often derive from predicted domains, homologies, or structural features inferred from gene sequencing data. For instance, the "SCP2" portion of the name suggests a potential relationship to Sterol Carrier Protein 2, which is involved in lipid transfer and metabolism, although this is speculative without direct evidence. The "Domain Containing 1" part implies that this protein might contain a specific domain, similar to one found in Sterol Carrier Protein 2, which might mediate a particular function or interaction with other molecules.In general, proteins that carry the SCP2 domain are implicated in the intracellular transport of lipids, which is crucial for various metabolic processes, including lipid synthesis, breakdown, and conversion into other biologically active molecules. These proteins can participate in maintaining cellular lipid homeostasis, contributing to the proper function of membranes and the production of signaling molecules.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which can modulate lipid metabolism pathways potentially influencing SCP2D1. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
An HMG-CoA reductase inhibitor, lovastatin affects cholesterol synthesis, potentially impacting SCP2D1-related pathways. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
As a PPARα agonist, fenofibrate modulates lipid metabolism, which could indirectly affect SCP2D1. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPARγ agonist, rosiglitazone influences lipid metabolism and could indirectly impact SCP2D1. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
A primary bile acid, cholic acid is involved in lipid digestion and absorption, potentially affecting SCP2D1. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Another PPARα agonist, gemfibrozil modulates lipid metabolism, potentially influencing SCP2D1. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Influences lipid metabolism, potentially impacting SCP2D1-related pathways. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Similar to lovastatin, as an HMG-CoA reductase inhibitor, simvastatin could affect SCP2D1. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Inhibits lipase, impacting lipid digestion and absorption, potentially influencing SCP2D1. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Inhibits cholesterol absorption, potentially impacting SCP2D1-related pathways. | ||||||